$2.81
0.093.31%
At close: -
$2.72
-0.09-3.20%
After Hours: Oct 30, 5:54 PM EDT
15 minutes delayed
Burning Rock Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Burning Rock Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-28 | $-3.10 | $-3.80 | 18.4 % |
Sep 2022 | 2022-11-15 | $-3.10 | $-3.20 | 3.12 % |
Jun 2022 | 2022-08-31 | $-3.70 | $-3.50 | -5.71 % |
Mar 2022 | 2022-05-31 | $-3.90 | $-3.60 | -8.33 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-28 | $20.62M | $16.10M | 28.1 % |
Sep 2022 | 2022-11-15 | $21.74M | $21.15M | 2.78 % |
Jun 2022 | 2022-08-31 | $19.53M | $22.15M | -11.8 % |
Mar 2022 | 2022-05-31 | $21.38M | $20.81M | 2.73 % |
Burning Rock Biotech (BNR) is scheduled to report earnings on November 29, 2024. The last reported earnings were for reported on August 22, 2024 for Q2.
The Actual EPS was $-1.40, which missed the estimate of $0.00.
The Actual Revenue was $18.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.